Lion TCR is a biopharmaceutical firm that develops T-cell therapy for the treatment of cancer. Lion TCR was founded in 2015. Lion TCR's headquarters is located in Other, SG 138673. It has raised 20.0M in 1 round. The latest round was in May 2018. Lion...
Lion TCR's Co-Founder & CEO, Lietao Li, currently has an approval
rating of 70%. Lion TCR's primary competitors are
There are no competitors identified for Lion TCR
There have been no acquisitions found related to Lion TCR
Recent investment data cannot be found related to Lion TCR